Skip to main content

Advertisement

Log in

The Presence of Complementary and Alternative Medicine Recommendations in Head and Neck Cancer Guidelines: Systematic Review and Quality Assessment

  • Integrative Care (C Lammersfeld, Section Editor)
  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Purpose of review

A high proportion of head and neck cancer (HNC) patients use complementary and alternative medicine (CAM), however, healthcare professionals generally have little knowledge about the safety and efficacy of these therapies. The purpose of this study was to determine the quantity and assess the quality of CAM recommendations across clinical practice guidelines (CPGs) for the treatment and/or management of HNC.

Recent findings

MEDLINE, EMBASE, and CINAHL were systematically searched for HNC CPGs published between 2009 and April 2020; the Guidelines International Network and the National Center for Complementary and Integrative Health websites were also were searched. Eligible CPGs containing CAM recommendations were assessed twice with the Appraisal of Guidelines, Research and Evaluation II (AGREE II) instrument, once for the overall CPG and once for the CAM sections. Of 305 unique search results, 7 CPGs mentioned CAM and 4 CPGs made CAM recommendations. The overall CPG scored higher than the CAM section for 4 of 6 domains (overall, CAM): scope and purpose (93.8%, 93.8%), clarity of presentation (88.2%, 64.6%), stakeholder involvement (68.8%, 39.6%), rigor of development (58.3%, 34.6%), editorial independence (42.7%, 42.7%), and applicability (51.6%, 19.8%). Quality varied within and between CPGs.

Summary

Highly scoring CPGs serve as evidence-based resources that clinicians can use to inform their patients about safe and effective CAM use; CPGs achieving variable or lower scores could be improved in future updates based on currently available guideline development/implementation tools. Future research should identify CAM therapies supported by sufficient evidence to be included as part of HNC CPGs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

All relevant data are included in this manuscript.

Abbreviations

AGREE II:

Appraisal of Guidelines for Research & Evaluation II

CAM:

complementary and alternative medicine

CIM:

complementary and integrative medicine

CPG:

clinical practice guideline

HNC:

head and neck cancer

NCCIH:

National Center for Complementary and Integrative Health

PICO:

Patients, Intervention, Comparison and Outcomes

PRISMA:

Preferred Reporting Items for Systematic Reviews and Meta-Analyses

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Head and neck cancer guide. Cancer.Net Doctor Approved Patient Information from ASCO. 2020. https://www.cancer.net/cancer-types/head-and-neck-cancer/introduction. Accessed 14 Jun 2020.

  2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

    Google Scholar 

  3. Vigneswaran N, Williams MD. Epidemiological trends in head and neck cancer and aids in diagnosis. Oral Maxillofac Surg Clin North Am. 2014;26(2):123–41.

    Article  Google Scholar 

  4. •• Matovina C, Birkeland AC, Zick S, Shuman AG. Integrative medicine in head and neck cancer. Otolaryngol Head Neck Surg. 2017;156(2):228–37 This article synthesized recently published data to illustrate the decision-making inherent in the use of integrative medicine among patients with head and neck cancer, to address the ethical issues inherent in combining integrative and traditional treatment methods, and to highlight available tools to enhance awareness of integrative medicine by the providers of head and neck cancer. It also provides important implications for practice.

    Article  Google Scholar 

  5. Complementary, alternative, or integrative health: What’s in a name? National Institutes of Health, National Centre for Complementary and Integrative Health (NCCIH). 2016. https://nccih.nih.gov/health/integrative-health. Accessed 14 Jun 2020.

  6. Miller MC, Pribitkin EA, Difabio T, Keane WM. Prevalence of complementary and alternative medicine use among a population of head and neck cancer patients: a survey-based study. Ear Nose Throat J. 2010;89(10):E23–7.

    Article  Google Scholar 

  7. Vyas T, Hart RD, Trites JR, Philips TJ, Archibald KEM, Phillips JE, et al. Complementary and alternative medicine use in patients presenting to a head and neck oncology clinic. Head Neck. 2010;32(6):793–9.

    PubMed  Google Scholar 

  8. Molassiotis A, Ozden G, Platin N, Scott JA, Pud D, Fernandez-Ortega P, et al. Complementary and alternative medicine use in patients with head and neck cancers in Europe. Eur J Cancer Care. 2006;15:19–24.

    Article  CAS  Google Scholar 

  9. Hendershot KA, Dixon M, Kono SA, Shin DM, Pentz RD. Patients’ perceptions of complementary and alternative medicine in head and neck cancer: a qualitative, pilot study with clinical implications. Complement Ther Clin Pract. 2014;20(4):213–8.

    Article  Google Scholar 

  10. Clinical practice guideline manual. American Academy of Family Physicians (AAFP). 2017. https://www.aafp.org/patient-care/clinical-recommendations/cpg-manual.html. Accessed 23 Jun 2020.

  11. •• Anaya MVM, Franco JV, Merchan-Glavis AM, Gallardo CR, Cosp XB. Quality assessment of clinical practice guidelines on treatments for oral cancer. Cancer Treat Rev. 2018;65:47–53 This article is the first to provide a quality assessment of clinical practice guidelines for the treatment of oral cancer. This study is the only one to assess a subset of head and neck cancer clinical practice guidelines to date, finding that in general, the quality of the guidelines assessed was suboptimal.

    Article  Google Scholar 

  12. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; 2011. https://handbook-5-1.cochrane.org. Accessed 30 Jun 2020.

  13. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.

    Article  Google Scholar 

  14. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Can Med Assoc J. 2010;182(18):E839–42.

    Article  Google Scholar 

  15. Nekhlyudov L, Lacchetti C, Davis NB, Garvey TQ, Goldstein DP, Nunnink JC, et al. Head and neck cancer survivorship care guideline: American Society of Clinical Oncology clinical practice guideline endorsement of the American Cancer Society guideline. J Clin Oncol. 2017;35(14):1606–21.

    Article  Google Scholar 

  16. Choo PK, Ahmad A, Hassan F, Yusoff FM, Kamaruzaman HF, Kassim KNBM, Han KM, Yusof MAM, Noor MKM et al. Management of Nasopharyngeal Carcinoma. Malaysia Health Technology Assessment Section (MaHTAS). 2016. Available from: https://www.researchgate.net/publication/316033175_Clinical_Practice_Guidelines_CPG_on_Management_of_Nasopharyngeal_Carcinoma. Accessed 29 Jun 2020.

  17. Cocks H, Ah-See K, Capel M, Taylor P. Palliative and supportive care in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130(Suppl. 2):S198–207.

    Article  CAS  Google Scholar 

  18. Cohen EEW, LaMonte SJ, Erb NL, Beckman KL, Sadeghi N, Hutcheson KA, et al. American Cancer Society Head and Neck Cancer Survivorship Care Guideline. CA Cancer J Clin. 2016;66(3):203–39.

    Article  Google Scholar 

  19. Talwar B, Donnelly R, Skelly R, Donaldson M. Nutritional management in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130(Suppl. 2):S142–9.

    Google Scholar 

  20. Cuny F, Babin E, Lacau-Saint-Guily J, Baujat B, Bensadoun R, Bozec A, et al. French Society of ENT (SFORL) guidelines for care pathway organization in head and neck oncology (short version). Early management of head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis. 2015;132:205–8.

    Article  CAS  Google Scholar 

  21. Pfister DG, Ang K-K, Brizel D, Burtness BA, Busse PM, Caudell JJ, et al. Head and neck cancers. J Natl Compr Cancer Netw. 2011;9(6):596–650.

    Article  Google Scholar 

  22. • Ng JY, Nault H, Nazir Z. Complementary and integrative medicine mention and recommendations: a systematic review and quality assessment of lung cancer clinical practice guidelines. Integr Med Res. 2020:100452. https://doi.org/10.1016/j.imr.2020.100452. This article is the first to provide a systematic review of complementary and integrative medicine recommendations and conduct a quality assessment across clinical practice guidelines for the treatment and/or management of lung cancer. Finding very few recommendations overall, this study highlights a major knowledge gap, which may hinder informed shared-decision making between practitioner and provider regarding safe and effective CAM use, especially provided that most healthcare practitioners in oncology have little to no training in this topic area.

  23. Ng JY, Sharma AE. Guidelines for Cancer‐Related Pain: A Systematic Review of Complementary and Alternative Medicine Recommendations. Pain Practice. 2020 Nov 16. https://doi.org/10.1111/papr.12964

  24. • Ng JY, Thakar H. Complementary and alternative medicine mention and recommendations are lacking in colon cancer clinical practice guidelines: A systematic review. Adv Integr Med. 2020. https://doi.org/10.1016/j.aimed.2020.06.002. This article is the first to provide a systematic review of complementary and alternative medicine recommendations and conduct a quality assessment across clinical practice guidelines for the treatment and/or management of colon cancer. Finding no recommendations overall, this study highlights a major knowledge gap, which may hinder informed shared-decision making between practitioner and provider regarding safe and effective CAM use, especially provided that most healthcare practitioners in oncology have little to no training in this topic area.

  25. Ng JY, Lau SK. Complementary and alternative medicine status in ovarian cancer guidelines: A systematic review. European Journal of Integrative Medicine. 2020 Oct 17:101227. https://doi.org/10.1016/j.eujim.2020.101227

  26. Ng JY, Mohiuddin U. Quality of complementary and alternative medicine recommendations in low back pain guidelines: a systematic review. Eur Spine J. 2020;29:1833–44. https://doi.org/10.1007/s00586-020-06393-9.

    Article  PubMed  Google Scholar 

  27. Ng JY, Liang L, Gagliardi AR. The quantity and quality of complementary and alternative medicine clinical practice guidelines on herbal medicines, acupuncture and spinal manipulation: systematic review and assessment using AGREE II. BMC Complement Altern Med. 2016;16(425):1.

    Google Scholar 

  28. Warrick PD, Irish JC, Morningstar M, Gilbert R, Brown D, Gullane P. Use of alternative medicine among patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 1999;125(5):573–9.

    Article  CAS  Google Scholar 

  29. Schünemann H, Brożek J, Guyatt G, Oxman A (editors). GRADE handbook for grading quality of evidence and strength of recommendations. The GRADE Working Group. 2013. Available from: guidelinedevelopment.org/handbook. Accessed 30 Jun 2020.

  30. Treweek S, Oxman AD, Alderson P, Bossuyt PM, Brandt L, Brożek J, et al. Developing and evaluating communication strategies to support informed decisions and practice based on evidence (DECIDE): protocol and preliminary results. Implement Sci. 2013;8:6.

    Article  Google Scholar 

  31. Shiffman RN, Michel G, Rosenfeld RM, Davidson C. Building better guidelines with BRIDGE-wiz: development and evaluation of a software assistant to promote clarity, transparency, and implementability. J Am Med Inform Assoc. 2012;19(1):94–101.

    Article  Google Scholar 

  32. Shiffman RN, Dixon J, Brandt C, Essaihi A, Hsiao A, Michel G, et al. The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation. BMC Med Inform Decis Mak. 2005;5(1):23.

    Article  Google Scholar 

  33. Shiffman RN. GuideLines into DEcision support (GLIDES). In: Center for Medical Informatics. Yale School of Medicine. Updated 2019. Available at: https://medicine.yale.edu/cmi/glides/about_glides/. Accessed 30 Jun 2020.

  34. Tools. In: Library& Resources / Tools. Guidelines International Network. 2020. Available from https://g-i-n.net/library/tools. Accessed 30 Jun 2020.

Download references

Acknowledgments

We gratefully acknowledge Manav Nayeni for assisting with screening and data extraction.

Funding

JYN was funded by a Research Scholarship and an Entrance Scholarship from the Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences at McMaster University.

Author information

Authors and Affiliations

Authors

Contributions

JYN: designed and conceptualized the study, collected and analysed data, co-drafted the manuscript, and gave final approval of the version to be published.

ED: assisted with the collection and analysis of data, co-drafted the manuscript, and gave final approval of the version to be published.

Corresponding author

Correspondence to Jeremy Y. Ng.

Ethics declarations

Ethics Approval and Consent to Participate

This study involved a systematic review of peer-reviewed literature only; it did not require ethics approval or consent to participate.

Consent for Publication

All authors consent to this manuscript’s publication.

Competing Interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Integrative Care

Supplementary Information

Supplementary File 1

MEDLINE Search Strategy for HNC CPGs Executed April 17th, 2020 (DOCX 26 kb).

Supplementary File 2

Modified AGREE II Questions Used to Guide Scoring of CAM Sections of Each CPG. Note: All Supplementary Files were created by the authors and do not require permission to reproduce (XLSX 14 kb).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ng, J.Y., Dogadova, E. The Presence of Complementary and Alternative Medicine Recommendations in Head and Neck Cancer Guidelines: Systematic Review and Quality Assessment. Curr Oncol Rep 23, 32 (2021). https://doi.org/10.1007/s11912-021-01024-y

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11912-021-01024-y

Keywords

Navigation